Atlas Trials

Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of ACD856

Clinical trial NCT05077501 · COMPLETED

Trial details

NCT number
NCT05077501
Sponsor
AlzeCure Pharma
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Alzheimer DiseaseCognition Disorder
Start date
2021-09-29
Primary completion
2022-05-16
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.